ADARx Pharmaceuticals, Inc.

CIK 1802369 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ADARx Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 4, 2026S-10001193125-26-383838
Aug 10, 2023D0001802369-23-000002
Jan 26, 2023D0001802369-23-000001
Aug 17, 2021D0001802369-21-000004
May 24, 2021D0001802369-21-000003
Nov 17, 2020D0001802369-20-000004
Aug 7, 2020D0001802369-20-000002
Feb 6, 2020D0001802369-20-000001